For a study, researchers sought to see if patients with chronic lymphocytic leukemia (CLL) who were treated at Commission on Cancer accredited academic centers (ACs), which had a high clinical volume, access to clinical trials,...
Read More
For a study, researchers sought to look at how patient characteristics and treatment patterns for...
Read More
Leukemia was the seventh most prevalent cause of mortality among cancer patients. It was...
Read More
During their hospitalization for rigorous chemotherapy, patients with Acute Myeloid Leukemia (AML)...
Read More
While the cause of multiple sclerosis (MS) was unknown, evidence showed that herpesviruses (HVs),...
Read More
Health professionals have urged studies to measure people’s “happiness” by...
Read More
Even though spasticity is prevalent, persons with multiple sclerosis (MS) with spasticity (PwMSS)...
Read More
Women of reproductive age were more likely to be diagnosed with multiple sclerosis (MS). Although...
Read MoreThe CMSC Annual Meeting provides a variety of credit offerings for attendees. Physician attendees can earn up to 18.0 AMA PRA Category 1 CreditsTM over the course of the meeting. Physician Assistants can earn up to 18.0 AAPA...
Read MoreStrongly Recommended In all conference and meeting rooms, you should wear your mask. Presenters and moderators/panelists can remove their mask when speaking. In standing room spaces, when engaged in extended conversation or are...
Read More
Advancing Advocacy in MS: Access to Affordable, High-Quality Care and Treatments Wednesday, June 1 at 8:00 am Delivering Patient-Centered, Equitable Multiple Sclerosis Care: The Latest Evidence and Real-World Perspectives...
Read More
Focus on MS MAY 2022v2.indd
Read More
In women with multiple sclerosis (MS) and clinically isolated syndrome (CIS), continuing disease...
Read More
In patients in the earlier stages of MS, an accelerated rate of spinal cord atrophy can indicate...
Read More
“It has previously been thought that [multiple sclerosis (MS)] is less common among non-European...
Read More
“Identifying an accurate prognostic biomarker in individuals with multiple sclerosis (MS) is...
Read MoreElevated levels of neurofilament light chain (NfL) are a known biomarker for neurodegeneration in conditions such as stroke, dementia, Multiple sclerosis, and Amyotrophic lateral sclerosis. A new study reveals that NfL may also...
Read More
Patients with relapsing multiple sclerosis (RMS) achieved No Evidence of Disease Activity (NEDA)...
Read More
